World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
74
Citations
18276
World Ranking
2064
National Ranking
82

Claudio Tripodo publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Claudio Tripodo sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 465 publications — 87th percentile

87% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Claudio Tripodo D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Claudio Tripodo sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 74 D-Index — 59th percentile

59% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Claudio Tripodo is affiliated with the University of Palermo in Italy and has a research focus primarily in the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their body of work includes significant contributions to Immunology, Oncology, Molecular Biology, Pathology and Forensic Medicine, and Cell Biology.

The scientist's research centers on several key topics, including:

  • Lymphoma Diagnosis and Treatment
  • Cancer Immunotherapy and Biomarkers
  • Immune cells in cancer
  • Immune Cell Function and Interaction
  • CAR-T cell therapy research
  • Immunotherapy and Immune Responses
  • Chronic Lymphocytic Leukemia Research

Claudio Tripodo has published articles in a variety of scientific venues, with notable frequency in:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Cancer Research
  • Hematological Oncology
  • Nature Communications
  • Journal of Experimental & Clinical Cancer Research

Recent publications include:

  • "YAP/TAZ activity in stromal cells prevents ageing by controlling cGAS-STING", 2022, Nature
  • "SARS-CoV2 vertical transmission with adverse effects on the newborn revealed through integrated immunohistochemical, electron microscopy and molecular analyses of Placenta", 2020, EBioMedicine
  • "Compromised nuclear envelope integrity drives TREX1-dependent DNA damage and tumor cell invasion", 2021, Cell
  • "Gut Microbiota Condition the Therapeutic Efficacy of Trastuzumab in HER2-Positive Breast Cancer", 2021, Cancer Research
  • "Tumor-Derived Prostaglandin E2 Promotes p50 NF-κB-Dependent Differentiation of Monocytic MDSCs", 2020, Cancer Research

Collaborations play a substantial role in their work, with frequent co-authors including:

  • Valeria Cancila
  • Mario P. Colombo
  • Sabina Sangaletti
  • Claudia Chiodoni
  • Beatrice Belmonte

Best Publications

  • Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4.

    Matilde Todaro;Mileidys Perez Alea;Anna B. Di Stefano;Patrizia Cammareri

  • Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C

    Salvatore Petta;Calogero Cammà;Concetta Scazzone;Claudio Tripodo

  • CD4+CD25+ regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction.

    Giorgia Gri;Silvia Piconese;Barbara Frossi;Vanessa Manfroi

  • Neutrophil extracellular traps mediate transfer of cytoplasmic neutrophil antigens to myeloid dendritic cells toward ANCA induction and associated autoimmunity.

    Sabina Sangaletti;Claudio Tripodo;Claudia Chiodoni;Carla Guarnotta

  • Antibody–Fc/FcR Interaction on Macrophages as a Mechanism for Hyperprogressive Disease in Non–small Cell Lung Cancer Subsequent to PD-1/PD-L1 Blockade

    Giuseppe Lo Russo;Massimo Moro;Michele Sommariva;Valeria Cancila

  • Dynamics of complement activation in aHUS and how to monitor eculizumab therapy

    Marina Noris;Miriam Galbusera;Sara Gastoldi;Paolo Macor

  • C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation

    Roberta Bulla;Claudio Tripodo;Damiano Rami;Guang Sheng Ling

  • Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis

    Francesco Ciccia;Michele Bombardieri;Alfonso Principato;AnnaRita Giardina

  • Splenic marginal zone lymphoma: a prognostic model for clinical use

    Luca Arcaini;Mario Lazzarino;Nora Colombo;Sara Burcheri

  • Plasmacytoid dendritic cells promote systemic sclerosis with a key role for TLR8

    Marie Dominique Ah Kioon;Claudio Tripodo;David Fernandez;Kyriakos A. Kirou

  • SARS-CoV2 vertical transmission with adverse effects on the newborn revealed through integrated immunohistochemical, electron microscopy and molecular analyses of Placenta.

    Fabio Facchetti;Mattia Bugatti;Emma Drera;Claudio Tripodo

  • RNA recognition by human TLR8 can lead to autoimmune inflammation

    Cristiana Guiducci;Mei Gong;Alma Martina Cepika;Zhaohui Xu

  • Mast cells counteract regulatory T-cell suppression through interleukin-6 and OX40/OX40L axis toward Th17-cell differentiation

    Silvia Piconese;Giorgia Gri;Claudio Tripodo;Silvia Musio

  • Autoimmune skin inflammation is dependent on plasmacytoid dendritic cell activation by nucleic acids via TLR7 and TLR9

    Cristiana Guiducci;Claudio Tripodo;Mei Gong;Sabina Sangaletti

  • Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome

    Andrea Rinaldi;Michael Mian;Ekaterina Chigrinova;Luca Arcaini

  • RORC1 Regulates Tumor-Promoting “Emergency” Granulo-Monocytopoiesis

    Laura Strauss;Sabina Sangaletti;Francesca Maria Consonni;Gabor Szebeni

  • Human Bone Marrow Mesenchymal Stem Cells Display Anti-Cancer Activity in SCID Mice Bearing Disseminated Non-Hodgkin's Lymphoma Xenografts

    Paola Secchiero;Sonia Zorzet;Claudio Tripodo;Federica Corallini

  • Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition

    M R Sapienza;F Fuligni;C Agostinelli;C Tripodo

  • In vivo targeting of human neutralizing antibodies against CD55 and CD59 to lymphoma cells increases the antitumor activity of rituximab.

    Paolo Macor;Claudio Tripodo;Sonia Zorzet;Erich Piovan

  • Unjamming overcomes kinetic and proliferation arrest in terminally differentiated cells and promotes collective motility of carcinoma

    Andrea Palamidessi;Chiara Malinverno;Emanuela Frittoli;Salvatore Corallino

  • CD38/CD31, the CCL3 and CCL4 chemokines, and CD49d/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival.

    Antonella Zucchetto;Dania Benedetti;Claudio Tripodo;Riccardo Bomben

Frequent Co-Authors

Mario P. Colombo
Mario P. Colombo Fondazione IRCCS Istituto Nazionale dei Tumori
Francesco Tedesco
Francesco Tedesco University of Trieste
Stefano Pileri
Stefano Pileri European Institute of Oncology
Gianluca Gaidano
Gianluca Gaidano University of Eastern Piedmont Amadeo Avogadro
Valter Gattei
Valter Gattei University of Trieste
Silvia Deaglio
Silvia Deaglio University of Turin
Elda Tagliabue
Elda Tagliabue Fondazione IRCCS Istituto Nazionale dei Tumori
Antonio Craxì
Antonio Craxì University of Palermo
Fabio Malavasi
Fabio Malavasi University of Turin
Fabio Facchetti
Fabio Facchetti University of Brescia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, expanding your expertise with complementary nursing degrees can enhance career prospects. Many professionals pursue an accelerated FNP programs to quickly advance into family nurse practitioner roles. These programs offer a fast track for students aiming to enter clinical practice with robust patient care skills.

Transitioning within nursing specialties is also common. For example, moving from an FNP to acute care NP certification can open doors to more specialized, high-demand fields such as critical care. This pathway provides opportunities for career growth and greater impact in acute settings—details on this can be found in fnp to acute care certification.

For individuals without a nursing background, there are tailored options designed to start a nursing career online. Programs featured under online nursing programs for non nurses enable newcomers to gain essential credentials and enter the healthcare workforce effectively.

Understanding financial outcomes is equally important. Exploring data on how much does a dnp make helps prospective students and professionals gauge the return on investment for advanced nursing degrees like the Doctor of Nursing Practice, guiding informed career decisions.

Best Scientists Citing Claudio Tripodo

Trending Scientists

Recently Published Articles